SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces Conference Call and Webcast on Tuesday, July 24, 2012, to Discuss 36-Week 6-Minute Walk Test Results From the Phase IIb DMD Study